A BILL 
To direct the Secretary of Veterans Affairs to establish or 
update certain clinical practice guidelines of the Depart-
ment of Veterans Affairs, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Setting Treatment Op-
4
tions and Practices for Veteran Suicide and Substance 
5
Abuse Act’’ or the ‘‘STOP Veteran Suicide and Substance 
6
Abuse Act’’. 
7
00:44 Feb 19, 2020
H5867
2 
•HR 5867 IH
SEC. 2. ESTABLISHMENT BY DEPARTMENT OF VETERANS 
1
AFFAIRS AND DEPARTMENT OF DEFENSE OF 
2
CLINICAL PRACTICE GUIDELINES FOR CO-
3
MORBID MENTAL HEALTH CONDITIONS SUCH 
4
AS PTSD, MST, AND/OR TBI. 
5
(a) IN GENERAL.—Not later than two years after the 
6
date of the enactment of this Act, the Secretary of Vet-
7
erans Affairs, in consultation with the Secretary of De-
8
fense and the Secretary of Health and Human Services, 
9
shall complete the development of clinical practice guide-
10
lines for the treatment of post-traumatic stress disorder, 
11
military sexual trauma, and traumatic brain injury that 
12
is comorbid with substance use disorder or chronic pain. 
13
(b) WORK GROUP.— 
14
(1) ESTABLISHMENT.—In carrying out sub-
15
section (a), the Secretary of Veterans Affairs, the 
16
Secretary of Defense, and the Secretary of Health 
17
and Human Services shall create a Trauma and Co-
18
morbid Substance Use Disorder or Chronic Pain 
19
Work Group (in this section referred to as the 
20
‘‘Work Group’’). 
21
(2) MEMBERSHIP.—The work group created 
22
under paragraph (1) shall be comprised of individ-
23
uals that represent Federal Government entities and 
24
non-Federal Government entities with expertise in 
25
00:44 Feb 19, 2020
H5867
3 
•HR 5867 IH
the areas covered by the work group, including the 
1
following: 
2
(A) Academic institutions that specialize in 
3
research for the treatment of conditions de-
4
scribed in subsection (a). 
5
(B) The National Center for Posttraumatic 
6
Stress Disorder of the Department of Veterans 
7
Affairs. 
8
(C) The Office of the Assistant Secretary 
9
for Mental Health and Substance Use of the 
10
Department of Health and Human Services. 
11
(3) RELATION TO OTHER WORK GROUPS.—The 
12
Work Group shall be created and conducted in the 
13
same manner as other work groups for the develop-
14
ment of clinical practice guidelines for the Depart-
15
ment of Veterans Affairs and the Department of De-
16
fense. 
17
(c) MATTERS INCLUDED.—In developing the clinical 
18
practice guidelines under subsection (a), the Work Group, 
19
in consultation with the Post Traumatic Stress Disorder 
20
Work Group, Concussion-mTBI Work Group, Opioid 
21
Therapy for Chronic Pain Work Group, and Substance 
22
Use Work Group, shall ensure that the clinical practice 
23
guidelines include the following: 
24
(1) Guidance with respect to the following: 
25
00:44 Feb 19, 2020
H5867
4 
•HR 5867 IH
(A) The treatment of patients with post- 
1
traumatic stress disorder who are also experi-
2
encing a substance use disorder or chronic pain. 
3
(B) The treatment of patients experiencing 
4
a mental health condition, including anxiety, de-
5
pression, or post-traumatic stress disorder as a 
6
result of military sexual trauma who are also 
7
experiencing a substance use disorder or chron-
8
ic pain. 
9
(C) The treatment of patients with trau-
10
matic brain injury who are also experiencing a 
11
substance use disorder or chronic pain. 
12
(2) Guidance with respect to the following: 
13
(A) Appropriate case management for pa-
14
tients experiencing post-traumatic stress dis-
15
order that is comorbid with substance use dis-
16
order or chronic pain who transition from re-
17
ceiving care while on active duty in the Armed 
18
Forces to care from health care networks out-
19
side of the Department of Defense. 
20
(B) Appropriate case management for pa-
21
tients experiencing a mental health condition, 
22
including anxiety, depression, or post-traumatic 
23
stress disorder as a result of military sexual 
24
trauma that is comorbid with substance use dis-
25
00:44 Feb 19, 2020
H5867
5 
•HR 5867 IH
order or chronic pain who transition from re-
1
ceiving care while on active duty in the Armed 
2
Forces to care from health care networks out-
3
side of the Department of Defense. 
4
(C) Appropriate case management for pa-
5
tients experiencing traumatic brain injury that 
6
is comorbid with substance use disorder or 
7
chronic pain who transition from receiving care 
8
while on active duty in the Armed Forces to 
9
care from health care networks outside of the 
10
Department of Defense. 
11
(3) Guidance with respect to the treatment of 
12
patients who are still members of the Armed Forces 
13
and are experiencing a mental health condition, in-
14
cluding anxiety, depression, or post-traumatic stress 
15
disorder as a result of military sexual trauma that 
16
is comorbid with substance use disorder or chronic 
17
pain. 
18
(4) Guidance with respect to the assessment by 
19
the National Academies of Sciences, Engineering, 
20
and Medicine of the potential overmedication of vet-
21
erans, as required pursuant to the Senate report ac-
22
companying S. 1557, 115th Congress (Senate Re-
23
port 115–130), under the heading ‘‘Overprescription 
24
00:44 Feb 19, 2020
H5867
6 
•HR 5867 IH
Prevention Report’’ under the heading ‘‘COMMITTEE 
1
RECOMMENDATION’’. 
2
(d) RULE OF CONSTRUCTION.—Nothing in this sec-
3
tion shall be construed to prevent the Secretary of Vet-
4
erans Affairs and the Secretary of Defense from consid-
5
ering all relevant evidence, as appropriate, in creating the 
6
clinical practice guidelines required under subsection (a) 
7
or from ensuring that the final clinical practice guidelines 
8
developed under such subsection and subsequently up-
9
dated, as appropriate, remain applicable to the patient 
10
populations of the Department of Veterans Affairs and the 
11
Department of Defense. 
12
SEC. 3. UPDATE OF CLINICAL PRACTICE GUIDELINES FOR 
13
ASSESSMENT 
AND 
MANAGEMENT 
OF 
PA-
14
TIENTS AT RISK FOR SUICIDE BY TAKING 
15
INTO CONSIDERATION GENDER- AND AGE- 
16
SPECIFIC RISK FACTORS AND GENDER- AND 
17
AGE-SPECIFIC 
TREATMENT 
EFFICACY 
OF 
18
PHARMACOTHERAPY AND PSYCHOTHERAPY. 
19
(a) IN GENERAL.—Not later than two years after the 
20
date of the enactment of this Act, the Secretary of Vet-
21
erans Affairs and the Secretary of Defense, through the 
22
Assessment and Management of Patients at Risk for Sui-
23
cide Work Group (in this section referred to as the ‘‘Work 
24
Group’’), shall issue an update to the VA/DOD Clinical 
25
00:44 Feb 19, 2020
H5867
7 
•HR 5867 IH
Practice Guideline for Assessment and Management of 
1
Patients at Risk for Suicide. 
2
(b) MATTERS INCLUDED.—In carrying out the up-
3
date under subsection (a), the Work Group shall ensure 
4
that the clinical practice guidelines updated under such 
5
subsection includes the following: 
6
(1) Enhanced guidance with respect to the fol-
7
lowing: 
8
(A) Gender- and age-specific risk factors 
9
for suicide and suicidal ideation. 
10
(B) Gender- and age-specific treatment ef-
11
ficacy for depression and suicide prevention. 
12
(C) Gender- and age-specific pharmaco-
13
therapy efficacy. 
14
(D) Gender- and age-specific psychothera-
15
py efficacy. 
16
(2) Guidance with respect to the efficacy of al-
17
ternative therapies, other than psychotherapy and 
18
pharmacotherapy, including the following: 
19
(A) Yoga therapy. 
20
(B) Meditation therapy. 
21
(C) Equine therapy. 
22
(D) Other animal therapy. 
23
(E) Training and caring for service dogs. 
24
(F) Agri-therapy. 
25
00:44 Feb 19, 2020
H5867
8 
•HR 5867 IH
(G) Art therapy. 
1
(H) Outdoor sports therapy. 
2
(I) Music therapy. 
3
(J) Any other alternative therapy that the 
4
Work Group considers appropriate. 
5
(3) Guidance with respect to the findings of the 
6
Creating Options for Veterans’ Expedited Recovery 
7
Commission (commonly referred to as the ‘‘COVER 
8
Commission’’) established under section 931 of the 
9
Jason Simcakoski Memorial and Promise Act (title 
10
IX of Public Law 114–198; 38 U.S.C. 1701 note). 
11
(c) RULE OF CONSTRUCTION.—Nothing in this sec-
12
tion shall be construed to prevent the Secretary of Vet-
13
erans Affairs and the Secretary of Defense from consid-
14
ering all relevant evidence, as appropriate, in updating the 
15
VA/DOD Clinical Practice Guideline for Assessment and 
16
Management of Patients at Risk for Suicide, as required 
17
under subsection (a), or from ensuring that the final clin-
18
ical practice guidelines updated under such subsection re-
19
main applicable to the patient populations of the Depart-
20
ment of Veterans Affairs and the Department of Defense. 
21
Æ 
00:44 Feb 19, 2020
H5867
